Teriparatide (PTH (1–34)), an active recombinant human peptide sequence of the parathyroid hormone, an Food and Drug Administration-approved drug for osteoporosis treatment21, is a parathyroid hormone analog that stimulates chondrocyte proliferation and differentiation in addition to cartilage regeneration22. The gene discussed is PTH; the disease is osteoporosis.